Maria Stahl Madsen

Maria Stahl Madsen

Auto-generated profile, based on publicly available information

Maria Stahl Madsen

Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
MMMaria Stahl Madsen
Maria Stahl Madsen
RSRasmus Siersbæk
Rasmus Siersbæk
MBMichael Boergesen
Michael Boergesen
RNRonni Nielsen
Ronni Nielsen
SMSusanne Mandrup
Susanne Mandrup
Functional convergence of CD28 costimulation and TCR signaling is critical to T-cell activation and adaptive immunity. These receptors form complex microscale patterns within the immune synapse, although the impact of this spatial organization on cell signaling remains unclear. We investigate this cross talk using micropatterned surfaces that present ligands to these membrane proteins in order to control the organization of signaling molecules within the cell-substrate interface. While primary human CD4+ T cells were activated by features containing ligands to both CD3 and CD28, this functional convergence was curtailed on surfaces in which engagement of these two systems was separated by micrometer-scale distances. Moreover, phosphorylated Lck was concentrated to regions of CD3 engagement and exhibited a low diffusion rate, suggesting that costimulation is controlled by a balance between the transport of active Lck to CD28 and its deactivation. In support of this model, disruption of the actin cytoskeleton increased Lck mobility and allowed functional T-cell costimulation by spatially separated CD3 and CD28. In primary mouse CD4+ T cells, a complementary system, reducing the membrane mobility increased the sensitivity to CD3-CD28 separation. These results demonstrate a subcellular reaction-diffusion system that allows cells to sense the microscale organization of the extracellular environment.

5 October 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JMJesper Grud Skat Madsen
Jesper Grud Skat Madsen
MMMaria S. Madsen
Maria S. Madsen
ARAlexander Rauch
Alexander Rauch
STSofie Traynor
Sofie Traynor
EHElvira L. Van Hauwaert
Elvira L. Van Hauwaert
SMSusanne Mandrup
Susanne Mandrup

1 May 2010 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
LGLars Grøntved
Lars Grøntved
MMMaria S. Madsen
Maria S. Madsen
MBMichael Boergesen
Michael Boergesen
RRRobert G. Roeder
Robert G. Roeder
SMSusanne Mandrup
Susanne Mandrup
The Mediator subunit MED1/TRAP220/DRIP205/PBP interacts directly with many nuclear receptors and was long thought to be responsible for tethering Mediator to peroxisome proliferator-activated receptor (PPAR)-responsive promoters. However, it was demonstrated recently that PPARgamma can recruit Mediator by MED1-independent mechanisms. Here, we show that target gene activation by ectopically expressed PPARgamma and PPARalpha is independent of MED1. Consistent with this finding, recruitment of PPARgamma, MED6, MED8, TATA box-binding protein (TBP), and RNA polymerase II (RNAPII) to the enhancer and proximal promoter of the PPARgamma target gene Fabp4 is also independent of MED1. Using a small interfering RNA (siRNA)-based approach, we identify MED14 as a novel critical Mediator component for PPARgamma-dependent transactivation, and we demonstrate that MED14 interacts directly with the N terminus of PPARgamma in a ligand-independent manner. Interestingly, MED14 knockdown does not affect the recruitment of PPARgamma, MED6, and MED8 to the Fabp4 enhancer but does reduce their occupancy of the Fabp4 proximal promoter. In agreement with the necessity of MED14 for PPARgamma transcriptional activity, we show that knockdown of MED14 impairs adipogenesis of 3T3-L1 cells. Thus, MED14 constitutes a novel anchoring point between Mediator and the N-terminal domain of PPARgamma that is necessary for functional PPARgamma-mediated recruitment of Mediator and transactivation of PPARgamma subtype-specific target genes.

1 September 2013 in Molecular Endocrinology
Verified
Journal Article
Closed access
AHAnders Kristian Haakonsson
Anders Kristian Haakonsson
MMMaria Stahl Madsen
Maria Stahl Madsen
RNRonni Nielsen
Ronni Nielsen
ASAlbin Sandelin
Albin Sandelin
SMSusanne Mandrup
Susanne Mandrup
Peroxisome proliferator-activated receptor γ (PPARγ) is a master regulator of adipocyte differentiation, and genome-wide studies indicate that it is involved in the induction of most adipocyte genes. Here we report, for the first time, the acute effects of the synthetic PPARγ agonist rosiglitazone on the transcriptional network of PPARγ in adipocytes. Treatment with rosiglitazone for 1 hour leads to acute transcriptional activation as well as repression of a number of genes as determined by genome-wide RNA polymerase II occupancy. Unlike what has been shown for many other nuclear receptors, agonist treatment does not lead to major changes in the occurrence of PPARγ binding sites. However, rosiglitazone promotes PPARγ occupancy at many preexisting sites, and this is paralleled by increased occupancy of the mediator subunit MED1. The increase in PPARγ and MED1 binding is correlated with an increase in transcription of nearby genes, indicating that rosiglitazone, in addition to activating the receptor, also promotes its association with DNA, and that this is causally linked to recruitment of mediator and activation of genes. Notably, both rosiglitazone-activated and -repressed genes are induced during adipogenesis. However, rosiglitazone-activated genes are markedly more associated with PPARγ than repressed genes and are highly dependent on PPARγ for expression in adipocytes. By contrast, repressed genes are associated with the other key adipocyte transcription factor CCAAT-enhancer binding proteinα (C/EBPα), and their expression is more dependent on C/EBPα. This suggests that the relative occupancies of PPARγ and C/EBPα are critical for whether genes will be induced or repressed by PPARγ agonist.

1 June 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ABAnne Bugge
Anne Bugge
MSMajken Siersbæk
Majken Siersbæk
MMMaria S. Madsen
Maria S. Madsen
AGAnita Göndör
Anita Göndör
CRCarole Rougier
Carole Rougier
SMSusanne Mandrup
Susanne Mandrup
Uncoupling Proteins (UCPs) are integral ion channels residing in the inner mitochondrial membrane. UCP2 is ubiquitously expressed, while UCP3 is found primarily in muscles and adipose tissue. Although the exact molecular mechanism of action is controversial, it is generally agreed that both homologues function to facilitate mitochondrial fatty acid oxidation. UCP2 and -3 expression is activated by the peroxisome proliferator-activated receptors (PPARs), but so far no PPAR response element has been reported in the vicinity of the Ucp2 and Ucp3 genes. Using genome-wide profiling of PPARgamma occupancy in 3T3-L1 adipocytes we demonstrate that PPARgamma associates with three chromosomal regions in the vicinity of the Ucp3 locus and weakly with a site in intron 1 of the Ucp2 gene. These sites are isolated from the nearest neighboring sites by >900 kb. The most prominent PPARgamma binding site in the Ucp2 and Ucp3 loci is located in intron 1 of the Ucp3 gene and is the only site that facilitates PPARgamma transactivation of a heterologous promoter. This site furthermore transactivates the endogenous Ucp3 promoter, and using chromatin conformation capture we show that it loops out to specifically interact with the Ucp2 promoter and intron 1. Our data indicate that PPARgamma transactivation of both UCP2 and -3 is mediated through this novel enhancer in Ucp3 intron 1.

7 March 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SJSimon T. Jakobsen
Simon T. Jakobsen
RJRikke A. M. Jensen
Rikke A. M. Jensen
MMMaria S. Madsen
Maria S. Madsen
TRTina Ravnsborg
Tina Ravnsborg
CVChristian S. Vaagenso
Christian S. Vaagenso
RSRasmus Siersbæk
Rasmus Siersbæk